TipRanksTop Financial ExpertsInsidersShenzhen Hepalink Pharmaceutical Co., Ltd.

Shenzhen Hepalink Pharmaceutical Co., Ltd. Insider Profile

4 Followers
Shenzhen Hepalink Pharmaceutical Co., Ltd., Ten Percent Owner at Liminal BioSciences, holds 85.29M shares in Resverlogix (Ticker: TSE:RVX), holds 96.29M shares in Liminal BioSciences (Ticker: LMNL). Most recently, Shenzhen Hepalink Pharmaceutical Co., Ltd. Bought ― shares of Resverlogix on Aug 18, 2020 for an estimated value of 2.68M.
tipranks
Shenzhen Hepalink Pharmaceutical Co., Ltd.

Shenzhen Hepalink Pharmaceutical Co., Ltd.
Liminal BioSciences (LMNL)
Ten Percent Owner

Ranked #5,626 out of 78,170 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

+43.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1B
94.12%
5.88%
A breakdown of Shenzhen Hepalink Pharmaceutical Co., Ltd.'s holdings

Insider Roles

Liminal BioSciences
(LMNL)
Ten Percent Owner
Resverlogix
(RVX)
Ten Percent Owner
Roles that Shenzhen Hepalink Pharmaceutical Co., Ltd. holds in companies

Most Profitable Insider Trade

Stock:
Resverlogix
(RVX)
Rating:Informative Buy
Date:Dec 05, 2017 - Dec 05, 2018
Return:+100.00%
The most profitable trade made by Shenzhen Hepalink Pharmaceutical Co., Ltd.

Shenzhen Hepalink Pharmaceutical Co., Ltd.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Liminal BioSciences
Jan 14, 2013
Ten Percent Owner
Informative Buy
9.95M
$1.08B
Resverlogix
Aug 18, 2020
Ten Percent Owner
Informative Buy
2.68M
C$67.38M
List of latest transactions for each holding click on a transaction to see Shenzhen Hepalink Pharmaceutical Co., Ltd.'s performance on stock

Shenzhen Hepalink Pharmaceutical Co., Ltd. insider profile FAQ

What is the percentage of profitable transactions made by Shenzhen Hepalink Pharmaceutical Co., Ltd.?
The percentage of profitable transactions made by Shenzhen Hepalink Pharmaceutical Co., Ltd. is 67%.
    What is the average return per transaction made by Shenzhen Hepalink Pharmaceutical Co., Ltd.?
    The average return per transaction made by Shenzhen Hepalink Pharmaceutical Co., Ltd. is 43.00%.
      What stocks does Shenzhen Hepalink Pharmaceutical Co., Ltd. hold?
      Shenzhen Hepalink Pharmaceutical Co., Ltd. holds: LMNL, TSE:RVX stocks.
        What was Shenzhen Hepalink Pharmaceutical Co., Ltd.’s latest transaction?
        Shenzhen Hepalink Pharmaceutical Co., Ltd. latest transaction was an Informative Buy of C$2.68M.
          What was Shenzhen Hepalink Pharmaceutical Co., Ltd.'s most profitable transaction?
          Shenzhen Hepalink Pharmaceutical Co., Ltd.’s most profitable transaction was an Informative Buy of TSE:RVX stock on December 5, 2017. The return on the trade was 100.00%.
            What is Shenzhen Hepalink Pharmaceutical Co., Ltd.'s role in Liminal BioSciences?
            Shenzhen Hepalink Pharmaceutical Co., Ltd.'s role in Liminal BioSciences is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.